News: NirogStreet appoints former Morgan Stanley Singapore MD Ashutosh Sinha as Chief Strategy Officer

Appointments

NirogStreet appoints former Morgan Stanley Singapore MD Ashutosh Sinha as Chief Strategy Officer

An IIT Kanpur and IIM Calcutta Alumni, Sinha was MD, CEO of Morgan Stanley Investment Management, Singapore, and previously founded and was managing partner of Asian Hedge Fund, Amoeba Capital.
NirogStreet appoints former Morgan Stanley Singapore MD Ashutosh Sinha as Chief Strategy Officer

NirogStreet has appointed former Morgan Stanley MD Ashutosh Sinha as the Chief Strategy Officer (CSO). In the new role, Sinha will drive the continued rapid expansion of the Ayurveda tech platform to bring trust and deliver more impact of Ayurveda healthcare on patients globally.

The official communique states that the start-up will benefit from the extensive knowledge and experience he gained working as a global investor for 25 years.  

An IIT Kanpur and IIM Calcutta Alumni, Ashutosh was MD, CEO of Morgan Stanley Investment Management, Singapore, and previously founded and was managing partner of Asian Hedge Fund, Amoeba Capital.

Commenting on Sinha’s appointment, CEO Ram N Kumar said, “We are aggressively moving towards our vision of becoming the world’s best global Ayurveda tech brand crafted in India for the world. Young leaders, industry veterans, and talents from across the globe are now looking towards NirogStreet as an aspirational Ayurveda brand. This is a testament to our efforts in promoting India’s ancient healthcare science on the global stage.” 

He further added that Sinha has joined as CSOr to solidify and expand NirogStreet's growth and market penetration strategy. The leadership is confident with him coming on board the company will grow multifold in the years to come.

Sinha shared, "I firmly believe that Ayurveda is the future of global healthcare – the holistic ancient science that focuses on the individual as a whole and not just the disease. I see a massive growth opportunity for a company like NirogStreet to bring tech-enabled and trusted Ayurveda solutions to the world. I have been associated as an investor with NirogStreet over the last few years and completely identify with their vision that Ayurveda has the potential to make the healthcare system of the future much more efficient and sustainable. I am looking forward to working with the dynamic team of NirogStreet.”

Read full story

Topics: Appointments, C-Suite, #Movements

Did you find this story helpful?

Author

QUICK POLL

How do you envision AI transforming your work?